Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2800632
Reference Type
Technical Report
Title
Occupationally Induced Connective Tissue Disorders
Author(s)
Zschunke, E; Ziegler, V; Haustein U-F
Year
1990
Report Number
NIOSH/00208119
Volume
2nd Edition
Page Numbers
172-183
Abstract
Occupation related incidence of progressive systemic sclerosis (PSS) and scleroderma like diseases (SLD) was discussed. Epidemiologic studies on the role of silicon (7440213) (Si) dust in the induction of PSS and silicosis of the lungs among underground miners were considered. Workplaces such as mines and manufacturing plants in which exposure to Si must be taken into account were enumerated. The pathogenesis of Si induced PSS, and the role of immune mechanisms in the progression of the disease, were outlined. A review of SLD included vinyl-chloride disease (VC) in which exposure to polyvinyl-chloride (9002862) caused fibrotic and other connective tissue changes, and a discussion of the role of cellular immune mechanisms, especially the HLA antigens. Similarities and differences between VC and PSS were tabulated. Other SLD were caused by exposure to trichloroethylene (79016), benzene (71432), toluene (108883), xylene (1330207), and other solvents and cleaners. A morphea like scleroderma caused by exposure to bis(4-amino-3-methylcyclohexyl)methane (6864375) was reported in resin workers and SLD were also reported to result after drug therapy and breast implants. SLD lesions resulted in the toxic oil syndrome, in Spain, from the use of cooking oil contaminated with aniline (62533). Relationships between lupus erythematosus or dermatomyositis and occupational exposure were not confirmed.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity